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PRECLINICAL STUDIES
icrovascular Permeabilization and
ardiomyocyte Injury Provoked by Myocardial
ontrast Echocardiography in a Canine Model
ouglas L. Miller, PHD,* Edward M. Driscoll,† Chunyan Dou, MD,* William F. Armstrong, MD,‡
enedict R. Lucchesi, MD, PHD†
nn Arbor, Michigan
OBJECTIVES The aim of this research was to evaluate the potential for myocardial contrast echocardiog-
raphy (MCE) to provoke microscale bioeffects in a canine model.
BACKGROUND Myocardial contrast echocardiography induces bioeffects in rat hearts, but translation of such
results to larger animal models is uncertain.
METHODS Dogs were anesthetized and prepared for open- (n  22) or closed- (n  6) chest MCE.
Evans blue dye was injected intravenously as an indicator of microvascular leakage, and
propidium iodide was used to stain for irreversibly injured myocytes in frozen sections. The
contrast agent (Definity, Bristol-Myers Squibb Medical Imaging Inc., North Billerica,
Massachusetts) was diluted in saline and infused intravenously at 2 l/kg/min. Myocardial
contrast echocardiography in a short-axis (open-chest) or modified four-chamber view
(closed-chest) with 1:4 end systolic electrocardiogram triggering was performed at 1.5 MHz
for 10 min in a single imaging plane.
RESULTS Petechiae and leakage of Evans blue were observed in the ultrasound scan plane within the
anterior left ventricle. For 1.2 MPa and 2.2 MPa, open- or closed-chest MCE, Evans blue
content in tissue within the scan plane was significantly greater than in tissue outside this
plane. Counts of propidium-iodide-stained nuclei for 2.2 MPa open-chest MCE were also
significantly greater inside than outside the scan plane.
CONCLUSIONS In a canine model, MCE induces myocardial injury comparable to that seen in the rodent
model. (J Am Coll Cardiol 2006;47:1464–8) © 2006 by the American College of























eeveral intravenous (IV) ultrasound contrast agents have
een approved in the U.S. and other countries, primarily for
ntracardiac cavity opacification (1). Many other agents and
pplications are being explored (2). All commercial agents
onsist of a suspension of stabilized microbubbles designed
o interact strongly with diagnostic ultrasound, thus provid-
See page 1469
ng image enhancement. Although these agents appear to be
elatively free of risk from a pharmacological viewpoint, the
otential for adverse bioeffects of ultrasound contrast agents
rises from the interaction of ultrasound imaging pulses and
he stabilized microbubbles. This interaction is a form of
coustic cavitation, which is a well-recognized mechanism
or nonthermal bioeffects of ultrasound (3).
For myocardial contrast echocardiography (MCE), mi-
roscale effects have been observed in isolated rabbit hearts
4) and in vivo in rats (5–7). Microvascular leakage induced
ith different agents was similar when compared on the
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ccepted September 8, 2005.asis of the number of stabilized microbubbles (5). Histo-
ogically defined microlesions have been identified by in-
ammatory cell infiltration in samples taken 24 h after
CE in rats (6), and vital staining has shown that cardio-
yocytes are specifically involved within the microlesions
7). Previous studies in rodents have identified specific
ombinations of contrast dose, ultrasound power, delivery
ode, and scanning duration below which bioeffects are
voided, and above which they are uniformly produced
5,7). Of note, while many of the doses and ultrasound
owers used in previous work exceed what is currently
mployed clinically, they are within the allowable range for
linical work.
Translation of observations in rodents or ex-vivo prepa-
ations to larger animal models or to the clinical laboratory
s often difficult. Uncertainty persists with respect to the
elevance of microscale bioeffects seen in small animal
odels during MCE, owing to the differences in size and
ltrasound delivery conditions. Premature ventricular con-
ractions induced by MCE have been noted in rats (5) and
n humans (8), but microvascular and cellular injury have
ot been demonstrated in a large-animal model. The
urpose of the current study was to test the hypothesis that
ffects similar to those seen in rats can be produced in a
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nimal preparation. This investigation was conducted
ith the approval of the University Committee on the Use
nd Care of Animals, University of Michigan. A total of 28
ogs (25 female dogs) averaging 10.4  1.5 kg in weight
ere anesthetized with an IV injection of 30 mg/kg pento-
arbital. A cannula was inserted into the right jugular vein
or injections, and electrocardiogram (ECG) electrodes
ere applied to three legs. For open-chest echocardiography
n 22 dogs, the animal was intubated and ventilated. A
eft-lateral thoracotomy was performed to expose the heart,
hich was then suspended in a pericardial cradle. For six
losed-chest dogs, the animal was anesthetized, the venous
atheter inserted, and the ECG electrodes applied. The hair
as carefully removed over the abdomen at the diaphragm.
n 22 dogs (16 open- and 6 closed-chest), Evans blue dye in
aline was injected intravenously as a tracer for microvascu-
ar leakage at a dose of 50 mg/kg 5 min before MCE. In 6
pen-chest dogs, propidium iodide (PI) (1 mg/kg) was
lowly infused into the left atrium approximately 5 min after
he cessation of MCE, as a vital stain for irreversibly injured
ells (9).
ltrasound contrast agent. A new vial of Definity (Bristol-
yers Squibb Medical Imaging Inc., North Billerica, Mas-
achusetts) was prepared for each dog according to the
anufacturer’s instructions. For infusion, the agent first was
iluted to 20 l/ml with sterile saline in a 20-ml syringe.
he syringe was then mounted in a syringe pump (Model
1 plus, Harvard Apparatus, Holliston, Massachusetts) set
o deliver 0.1 ml/kg/min. The jugular vein catheter was
onnected directly to the syringe. The suspension was
nfused for 2 min before MCE, then for 10 min of MCE.
hus, the agent dose rate was 2 l/kg/min with a total dose
f 24 l/kg (20 l/kg during echocardiography).
ltrasound. An unmodified commercially available diag-
ostic ultrasound platform was used for all imaging (GE
ingmed System V, General Electric Co., Cincinnati,
hio) using a cardiac scanhead (FPA2.5). For the open-
hest dogs, an ultrasound probe cover was placed loosely
ver the probe, which was aimed vertically downward. The
nd of the probe cover was filled with degassed saline and
sed as a flexible 4-cm stand-off from the heart surface. This
rovided a clear short-axis view of the heart at the level of
he papillary muscles. For the closed-chest dogs, the probe
Abbreviations and Acronyms
IV  intravenous
LV  left ventricle/ventricular
MCE  myocardial contrast echocardiography
MI  mechanical index
MWRS  Mann-Whitney rank sum
PI  propidium iodide
RPA  rarefactional pressure amplitudeas coated with ultrasound coupling gel and pressed onto fhe abdomen and aimed horizontally at the heart using a
ing-stand arrangement. Transthoracic views, as used clin-
cally, were not possible in the small dogs, because the
natomical arrangement of lung tissue blocked the sector
can. The transabdominal view included attenuation by 3 to
cm of intervening tissue, and also was partly restricted by
he lungs. Initial real-time imaging at a transmit frequency
f 1.5 MHz with a 36.4 Hz frame rate, 10 cm depth, and 5
m focus was used to aim the probe.
The peak rarefactional pressure amplitude (peak RPA)
roduced by the phased array system was measured in a
ater bath, as described previously (5). The peak RPA was
djusted by the power control to provide either 2.2 MPa
r 1.2 MPa. These correspond to equivalent mechanical
ndex (MI) values (the peak RPA divided by the square root
f the frequency) of 1.8 and 1.0, respectively (i.e., less than
he upper limit of 1.9 for diagnostic ultrasound). The RPA
ithin the myocardium was nonuniform with depth because
f the beam geometry for the 5-cm focal zone with the
aximum RPAs arranged to cover the anterior left ventric-
lar (LV) wall. For open-chest studies, single-image frames
ere triggered from the ECG signal each four beats at the
nd of systole. For the closed-chest model, attenuation
educed the RPA values. Assuming a nominal attenuation
f 0.5 dB/cm/MHz (3) over 4.0 cm between the probe and
eart surface, the peak RPA was reduced to 1.6 MPa
equivalent MI  1.3). Dual frames, 33 ms apart, were
riggered at four-beat intervals. For sham MCE, echocar-
iography was performed for 10 min, followed by injection
f the contrast agent with the ultrasound off. The MCE
mages together with ECG were recorded on videotape for
ater analysis.
xperimental plan and statistical analysis. For the open-
hest model, samples inside and outside the scan plane were
valuated for microvascular leakage in five hearts each for
he sham, 1.2 MPa, and 2.2 MPa conditions, and for PI
taining in three hearts with the MCE scan plane above the
ham MCE scan plane and three with the reverse place-
ent. Six closed-chest MCE hearts were evaluated for
icrovascular leakage. Numerical results are presented as
he mean  SD or plotted as the mean with standard error
ars. For statistical analysis (Sigmastat 3.1, Systat Software
nc., Point Richmond, California), paired Student t tests or
ann-Whitney rank sum (MWRS) tests (for data that
ailed tests for normalcy and equal variance) were used, with
tatistical significance assumed at p  0.05.
easured end points. Animals were euthanized 15 min
fter scanning by IV injection of a lethal dose of potassium
hloride, after which the heart was removed and perfused
ith 120 ml of heparinized saline. The exposure scan plane
as identified by a blue band formed by leakage of the dye
rom the microvasculature. Samples of myocardium were
btained from five myocardial strips, each 1-cm wide, cut
erpendicular to the blue band on the anterior LV as
ndicated in Figure 1. For each strip, a sample was taken
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ye was then extracted from the samples with formamide,
nd quantified using a spectrophotometer as described
reviously (5). For sham exposure, the positions of the
amples were selected to mimic those of the MCE samples.
or the closed-chest model, two strips were cut at the center
nd the results combined to give one result comparable to
he center strip cut for the open-chest model.
Cardiomyocyte injury was assessed using PI as a stain for
uclei of irreversibly injured cells (9). Samples taken for
istology after MCE showed contraction band necrosis and
etechial hemorrhage, as for the rat heart study (6), but
hese effects were not quantifiable. For the PI experiment, a
lightly different open-chest scanning procedure was used in
rder to combine sham and exposed conditions in each test.
en minutes of echocardiography without contrast agent
sham MCE) was completed, the probe was moved 2 cm,
nd 10 min of MCE was completed at the new position.
he sham MCE and MCE scan planes were alternately
cm above or below the scan position at the papillary
uscle used for the open-chest microvascular leakage tests.
issue samples were frozen, and 10-m sections were
ounted for examination under a fluorescence microscope.
ESULTS
pen-chest MCE at 2.2 MPa produced microvascular
eakage across the scan plane in all instances as shown in
igure 1. The blue band was 10- to 15-mm wide, and
xtended completely across the anterior surface of the LV. A
- to 5-mm wide mottled red band was also apparent, which
epresented erythrocyte extravasation (however, it was not
ossible to count individual petechiae on the surface of the
og hearts, which had been a sensitive end point in the rat
igure 1. Photograph of a heart after myocardial contrast echocardiogra-
hy in the open-chest model at 2.2 MPa. The blue band formed across the
eft ventricle at the ultrasound scan plane and records the microvascular
eakage, with irregular erythrocyte extravasation in the center of the band
arrows). The vertical lines indicate the orientation of tissue slices used for
amples A to E. Scale bar  1 cm.eart [5]). The interstitial blue dye and erythrocyte extrav-
a
bsation extended through the thickness of the anterior LV
all, as shown in Figure 2. The dye content was essentially
he same for all five sample positions (pNS). A blue band
as evident for the 1.2-MPa samples. Neither petechiae nor
vans blue leakage was evident for the sham samples. The
ean results for the center samples of each heart are shown
n Figure 3. In paired t tests, all the results were significantly
ifferent inside and outside the blue band (Fig. 3). In
npaired t tests, the closed-chest (p  0.02) and 2.2 MPa
pen-chest (p  0.001) results from inside the band were
ignificantly greater than the sham. The blue bands for the
losed-chest MCE hearts were not as well defined for the
pen-chest samples, as shown in Figure 4. Results, analyzed
n two samples each inside and outside the blue band, are
resented in Figure 3 for the six hearts (using averages of the
wo samples).
Six hearts were scored for PI staining; PI-stained nuclei
ere present around the periphery of sections, and red
utofluorescence in arterioles in the interior of samples was
resent in both sham and MCE. However, there was
onsistent enhancement of the number of red fluorescent
pots seen within the MCE band relative to the other
amples. Red fluorescent spots seen under low magnification
roved to contain clusters of several fluorescent nuclei when
xamined under high magnification. It was not possible to
etermine if these were cardiomyocyte or endothelial cells.
or counting the number of red fluorescent spots, four pho-
omicrographs (each covering 1.56 mm2) in red fluorescence
ere taken in the interior of a section and enhanced in contrast.
he processed images were scored blind. The scores for the
our frozen section photographs from each of three positions
n six dogs were 2.3 2.0/mm2 outside and 27.5 16.5/mm2
MWRS test, p  0.002) inside the scan plane.
igure 2. A photograph of a slice of the left ventricle cutting across the
can plane from the heart shown in Figure 1. The cut surface of the anterior
all is about 1-cm wide (two-headed arrow) and in focus with the interior
urface of the left ventricle falling out of focus to the right. The petechiae
nd Evans blue leakage penetrate through the anterior wall, and a blue
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he ECG record. No premature complexes were evident for
ither the sham, 1.2 MPa open-chest, or closed-chest
CE. For the open-chest 2.2 MPa microvascular leakage
ests, premature complexes averaged 120  64. For the PI
ests, the position was changed with MCE approximately 1
m above the previous position for three dogs and 1 cm
elow for three dogs. The premature complexes were 19 
2 and 4  4 for above and below, respectively, or 12  16
ombined. The combined premature complex count for the
I tests was significantly less than the count for the
icrovascular leakage tests (MWRS test, p 0.005), which
uggests some influence of scan position.
ISCUSSION
hese results, reported in a canine model of MCE, closely
arallel the results previously reported from our laboratory
sing a rat model of MCE. Both microvascular leakage and
ellular injury were demonstrated for high MI-triggered
maging. Our previous work was designed to delineate the
ange of bioeffects that occur and has identified the ranges
f ultrasound power, delivery mode, and contrast agent dose
elow which adverse bioeffects are minimized and above
hich bioeffects are uniformly produced (5,7).
Myocardial contrast echocardiography is a field in evolu-
igure 3. Results for microvascular leakage for sham exposure and open-
hest myocardial contrast echocardiography at 1.2 MPa, 2.2 MPa, and
losed-chest myocardial contrast echocardiography. Samples were obtained
rom inside and outside the blue band (or at the same positions for the
hams). The p values are for paired t tests comparing the inside and outside
easurements.ion for which multiple imaging algorithms have been
F
croposed, including low MI continuous imaging, intermit-
ent triggered high MI imaging, and burst imaging followed
y low MI imaging. Our previous work suggested that low
I imaging at a low dose of contrast agent is unlikely to
esult in bioeffects. Current MCE protocols typically utilize
ow MI imaging with only intermittent high MI bursts, and
t is unlikely that this more conservative algorithm would
esult in a similar degree of bioeffects as noted here.
owever, higher dose intermittent triggered imaging has
he potential to result in bioeffects, especially if combined
ith higher contrast agent doses or prolonged scanning
imes. While many of the imaging algorithms utilized in our
nimal work exceed the contrast dose, or ultrasound exposure
ime currently used in clinical practice, they are well within the
ange of commercially available clinical ultrasound platforms,
nd the lower doses resulting in adverse bioeffects have been
ithin the range of recommended doses.
Anecdotally, previous investigators have not noted similar
evels of capillary leakage or histologic disruption in numer-
us studies evaluating either the physiologic behavior of
CE or its diagnostic utility in open- and closed-chest
arge animal models. The reason for the absence of similar
ioeffects in the previous studies is most likely that Evans
lue dye was not used, and the hearts were not removed and
erfused to increase the contrast between the area of
icrovascular damage and the adjacent normal tissue. Fur-
hermore, the majority of MCE studies performed either in
he animal laboratory or clinically involved examination of
ultiple different scan planes rather than continuous pro-
onged imaging along a single scan plane. This has the effect
f “diluting out” the total ultrasound delivery to the myo-
ardium and would be expected to result in substantially less
bvious evidence of bioeffects.
tudy limitations. There are limitations to the research
eported here. First, the data obtained in a 10-kg canine may
ot translate with respect to ultrasound delivery to a normal-igure 4. A photograph of the blue band (arrows) generated by myocardial
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nd measured attenuation suggests that the more proximal
ardiac structures in a normal-sized adult would be subject to
imilar levels of ultrasound delivery using identical protocols.
econdly, in this study we evaluated only one contrast agent.
e have previously demonstrated equivalent bioeffects with
ultiple contrast agents that are quite similar in magnitude
fter correction for the number of microbubbles present in a
iven volume of the agent (5). Finally, this study involved
valuation of only one commercially available ultrasound plat-
orm. Whether similar bioeffects would be seen using other
ltrasound platforms remains conjectural.
onclusions. Bioeffects including evidence of capillary
eakage and irreversible tissue injury were identified in a
anine model of MCE using contrast doses and diagnostic
ltrasound delivery modes optimized for induction of ad-
erse bioeffects. These observations confirmed that bioef-
ects comparable to those seen in rats can occur in the larger
nimal model, and have direct relevance for avoiding bioef-
ects in the clinical setting.
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